To the full analysis
Buyback calculator for Myriad Genetics
Myriad Genetics stock: key metrics
MYGNMyriad Genetics had an operating margin of −8.2% and a return on invested capital (ROIC) of −9.2% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 80.4% | −30.4% | −22.3% |
| 2007 | 85.5% | 27.6% | no data |
| 2008 | 86.7% | 38.7% | no data |
| 2009 | 87.8% | 37.2% | 42.0% |
| 2010 | 88.4% | 39.2% | 25.0% |
| 2011 | 87.0% | 36.4% | 22.6% |
| 2012 | 87.0% | 37.2% | 24.0% |
| 2013 | 86.0% | 35.3% | 22.6% |
| 2014 | 79.6% | 18.6% | 11.1% |
| 2015 | 78.8% | 20.7% | 15.8% |
| 2016 | 76.5% | 6.0% | 2.4% |
| 2017 | 76.2% | 16.4% | 17.9% |
| 2018 | 76.4% | 0.9% | 0.5% |
| 2019 | 70.9% | −36.3% | −31.2% |
| 2021 | 71.4% | −27.6% | −3.9% |
| 2022 | 70.2% | −18.2% | −16.5% |
| 2023 | 68.6% | −19.2% | −35.0% |
| 2024 | 69.9% | −10.5% | −15.2% |
| 2025 | 69.9% | −8.2% | −44.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −10.3% | −29.9% | −9.3% |
| 2007 | no data | 54.8% | no data |
| 2008 | no data | 117.9% | no data |
| 2009 | 27.3% | 99.4% | 25.6% |
| 2010 | 17.8% | 53.1% | 16.5% |
| 2011 | 17.6% | 42.5% | 16.2% |
| 2012 | 20.2% | 44.2% | 18.3% |
| 2013 | 24.5% | 39.2% | 21.4% |
| 2014 | 12.1% | 15.2% | 10.5% |
| 2015 | 15.7% | 20.8% | 13.3% |
| 2016 | 2.3% | 3.4% | 1.4% |
| 2017 | 13.8% | 16.1% | 11.3% |
| 2018 | 0.4% | 0.6% | 0.3% |
| 2019 | −21.7% | −16.8% | −14.2% |
| 2021 | −2.8% | −17.3% | −2.1% |
| 2022 | −12.6% | −11.9% | −9.3% |
| 2023 | −33.6% | −13.4% | −23.0% |
| 2024 | −18.2% | −9.1% | −12.4% |
| 2025 | −99.4% | −9.2% | −51.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Apr 2019)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.